Reuters logo
BRIEF-Cadila Healthcare says ‍Zydus gets U.S. FDA approval for fesoterodine fumarate extended-release tablets​
October 5, 2017 / 6:14 AM / 16 days ago

BRIEF-Cadila Healthcare says ‍Zydus gets U.S. FDA approval for fesoterodine fumarate extended-release tablets​

Oct 5 (Reuters) - Cadila Healthcare Ltd

* Says ‍zydus receives final approval from USFDA for fesoterodine fumarate extended-release tablets​

* Says fesoterodine is used to treat an overactive bladder

* Says tablets to be manufactured at manufacturing facilitty at Moraiya Ahmedabad‍​

Source text for Eikon:

Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below